CIK: 1821189 - Address: C/O Kymera Therapeutics, Inc., 500 North Beacon Street, 4Th Floor, Watertown, MA 02472
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/12/22 19:30
1/10/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-2,55953.310-48-9472D
10/12/21 16:30
10/8/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-2,70556.340-48-9464D
8/5/21 16:14
8/3/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-40360.060-7-1452D
8/2/21 17:53
7/29/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-1,83260.250-30-6452D
7/28/21 16:57
7/26/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-77560.150-13-3452D
7/9/21 16:30
7/8/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.d-2,38649.700-48-10452D
6/11/21 16:15
6/10/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.d-1,18251.380-23-5412D
6/9/21 17:54
6/7/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-93950.100-19-4412D
5/14/21 17:20
5/12/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.d-41350.050-8-2397D
4/26/21 17:15
4/22/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-58040.230-14-4397D
4/19/21 19:12
4/15/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-22540.260-6-1397D
4/12/21 18:11
4/8/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMainolfi NelloMADOCEOS.dm-1,61433.620-48-11376D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact